Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Shake Shack (SHAK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Shake Shack (SHAK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Shake Shack (SHAK) reported $400.53 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 21.9%. EPS of $0.37 for the same period compares to $0.26 a year

Gap (GAP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Gap (GAP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Gap (GAP) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook gives a good

Wolverine (WWW) Reports Q4 Earnings: What Key Metrics Have to Say
Wolverine (WWW) Reports Q4 Earnings: What Key Metrics Have to Say

Wolverine World Wide (WWW) reported $517.5 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.6%. EPS of $0.45 for the same period compares to $0.42

Ero Copper Corp. (ERO) Reports Next Week: Wall Street Expects Earnings GrowthPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Ero Copper Corp. (ERO) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Ero Copper Corp. (ERO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy?
The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy?

The market expects The Cooper Companies (COO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known

Zacks.com featured highlights include BCB Bancorp, FirstSun Capital, Nomad Foods, Genesco and ASGN
Zacks.com featured highlights include BCB Bancorp, FirstSun Capital, Nomad Foods, Genesco and ASGN

For Immediate Release

Chicago, IL – February 26, 2026 – Stocks in this week’s article are BCB Bancorp, Inc. (BCBP), FirstSun Capital Bancorp FSUN, Nomad Foods Ltd. NOMD, Genesco Inc. GCO and ASGN

First Solar vs. Enphase Energy: Which Solar Stock Shines Now?
First Solar vs. Enphase Energy: Which Solar Stock Shines Now?

As renewable energy continues to grow, investors are paying more attention to companies that play important roles in the solar sector. Two widely followed names in this space are First Solar, Inc. F

Wolverine World Wide (WWW) Q4 Earnings and Revenues Top Estimates
Wolverine World Wide (WWW) Q4 Earnings and Revenues Top Estimates

Wolverine World Wide (WWW) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.42 per share a year ago

Warner Bros. Discovery (WBD) Reports Q4 Loss, Beats Revenue Estimates
Warner Bros. Discovery (WBD) Reports Q4 Loss, Beats Revenue Estimates

Warner Bros. Discovery (WBD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of $0.02. This compares to a loss of $0.2 per share a year ago. These figures are

Warby Parker Inc. (WRBY) Reports Break-Even Earnings for Q4
Warby Parker Inc. (WRBY) Reports Break-Even Earnings for Q4

Warby Parker Inc. (WRBY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.05. This compares to earnings of $0.01 per share a year ago. These figures are

NCR Voyix (VYX) Q4 Earnings and Revenues Beat Estimates
NCR Voyix (VYX) Q4 Earnings and Revenues Beat Estimates

NCR Voyix (VYX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to a loss of $0.08 per share a year ago. These figures are

Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.08 per share versus the Zacks Consensus Estimate of a loss of $0.9. This compares to a loss of $0.81 per share a year ago

Viatris (VTRS) Surpasses Q4 Earnings and Revenue Estimates
Viatris (VTRS) Surpasses Q4 Earnings and Revenue Estimates

Viatris (VTRS) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.54 per share a year ago. These figures

Millicom International Cellular SA (TIGO) Tops Q4 Earnings and Revenue Estimates
Millicom International Cellular SA (TIGO) Tops Q4 Earnings and Revenue Estimates

Millicom International Cellular SA (TIGO) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.2 per share a

Shake Shack (SHAK) Q4 Earnings Top Estimates
Shake Shack (SHAK) Q4 Earnings Top Estimates

Shake Shack (SHAK) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.26 per share a year ago. These

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $0.72 per share a year ago

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates

TG Therapeutics (TGTX) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.15 per share a year ago. These

Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates

Teleflex (TFX) came out with quarterly earnings of $1.93 per share, missing the Zacks Consensus Estimate of $3.73 per share. This compares to earnings of $3.89 per share a year ago. These figures

Smucker (SJM) Q3 Earnings and Revenues Surpass Estimates
Smucker (SJM) Q3 Earnings and Revenues Surpass Estimates

Smucker (SJM) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.61 per share a year ago. These figures are

United Parks & Resorts (PRKS) Lags Q4 Earnings and Revenue Estimates
United Parks & Resorts (PRKS) Lags Q4 Earnings and Revenue Estimates

United Parks & Resorts (PRKS) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.53 per share a year ago

Perrigo (PRGO) Q4 Earnings Lag Estimates
Perrigo (PRGO) Q4 Earnings Lag Estimates

Perrigo (PRGO) came out with quarterly earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.93 per share a year ago. These figures are

Playtika Holding (PLTK) Tops Q4 Earnings and Revenue Estimates
Playtika Holding (PLTK) Tops Q4 Earnings and Revenue Estimates

Playtika Holding (PLTK) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.03 per share a year ago. These

Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates

Indivior Pharmaceuticals Inc. (INDV) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.32 per share a year

International Seaways (INSW) Surpasses Q4 Earnings and Revenue Estimates
International Seaways (INSW) Surpasses Q4 Earnings and Revenue Estimates

International Seaways (INSW) came out with quarterly earnings of $2.45 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $0.9 per share a year ago

Kimbell Royalty (KRP) Tops Q4 Earnings and Revenue Estimates
Kimbell Royalty (KRP) Tops Q4 Earnings and Revenue Estimates

Kimbell Royalty (KRP) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to a loss of $0.1 per share a year ago. These